Hemp Inc (HEMP)

[albert]

Before I leave,Here is a Lovely OLD Article

You gonna Love it!
PS,Note the Date MAY 04,it was trading at $0.13,then to BOOM $1.25!!!
==============================

Blockbuster
Discovery!

A Publication of Stock Trader News
Jack Burney, Editor in Chief
May, 2004
Welcome to Blockbuster Discovery!

For this, our first issue, we have a stock profile worthy of the name: It’s all about a company with – get this -- a cure for a major “incurable” disease that is epidemic in the U.S. If you can’t make some serious money with this one, forget investing.

Jack Burney has a long and successful career in financial reporting. His first job was in the editorial room of The Wall Street Journal. He never got over that. With a Bachelor’s Degree in Journalism from SMU, he rose to Business Editor of a major metropolitan newspaper, and wrote a weekly column on OTC stocks. Later he became chief financial writer for The OTC News Network. He eventually established the Stock Trader News which publishes Jack’s Journal as well as profiles of companies about to take off in Biotech Fortunes and Hitech Fortunes.
READ ABOUT THIS AMAZING OPPORTUNITY IN PAGES THAT FOLLOW



18.2 MILLION PEOPLE
in the U.S. alone suffer from the debilitating effects of Type 2 Diabetes. They’ve been hoping and praying for this cure.

They will gladly pay anything to be free of the daily drudgery and the fearful dangers the diabetic faces every day.
To an investor, that means:
“Yes, there is a huge market waiting for a cure!”


BetaCure™
An End To Diabetes Type 2 Forever

That’s the tentative trade name of this blockbuster cure for Diabetes Type 2. There’s a little known herb that grows in the Middle East. It was discovered by the creator of BetaCure™. Let’s call him “The Doctor” because he doesn’t want to be identified as yet. He doesn’t want the notoriety that will come when this breakthrough becomes widely known.
The Doctor researched the herb for years, satisfying himself scientifically about its effectiveness. Finally, he was certain enough to conduct a test. The herb was dried, processed and compressed it into tablets.
He concluded that the BetaCure treatment regimen would take this form: 2 tablets a day for 8 weeks to cleanse and rejuvenate the pancreas. (That’s the organ that normally produces insulin, which regulates glucose in the body.)
Then the patient would begin taking just 1 tablet a month to maintain the health of the restored pancreas. All this was to be done under medical supervision and control.
He brought 40 Type 2 diabetics together to undergo his new BetaCure treatment. The results were startling:
40 Diabetics Treated. 40 Diabetics CURED !!!
This Blockbuster Cure
Will Lead Inevitably To
BLOCKBUSTER PROFITS

Do the math:
There are 18,200,000 Type 2 Diabetics in the US.
If, for example, only 3% or 546.000 a year receive
the BetaCure treatment, at a cost of only $5000 each...
546,000 x $5000 = Annual Sales of
$2,730,000,000
How Do YOU Get YOUR Share
Of That $2,730,000,000/Year?



Answer: Invest now in the company that owns
Exclusive Worldwide Rights to BetaCure:
HEE Corporation
(Trading Symbol: HCCF)
At this writing, the stock is selling at only 13 cents!

13 cents ?
for a stock that could easily sell one day at
over $200 per share
because HEE Corp. has a cure for Diabetes Type 2.

We’re not talking about a treatment for sore throat here. This is Diabetes 2 we’re curing – a life threatening disease – a potential killer - that is currently running wild in the US and the world.
HEE Corporation was founded for one purpose, and one purpose only:
To conduct formal testing and bring to market the blockbuster discovery: BetaCure.



Curing all 40 of the 40 diabetics tested by The Doctor was an unheard of success, but the evidence is “anecdotal” and not “scientific” in the medical profession’s definition of the term.

So HEE Corp. has contracted with a university in Northwestern Oregon to conduct controlled testing, first, of 10 individual Type 2 diabetics, and then of 300 to 500. The first test will begin this month. The treatment sequence takes only 8 weeks.

Other testing by university research departments is in the negotiating stage now. Corporate executives expect the testing to generate a scientifically accepted verification of the curative power of the herb.
The efficacy of BetaCure will be fully demonstrated before marketing begins.
To market and administer the BetaCure treatment, HEE Corp. will establish clinics throughout the country. Trained staff will keep a constant check on patients undergoing the 8-week treatment
First, the US. Then, the Rest of the World